Global and China Urological Cancer Therapeutics Drugs Market Insights, Forecast to 2027

Global and China Urological Cancer Therapeutics Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Urological Cancer Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Type
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Market by Application
1.3.1 Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Urological Cancer Therapeutics Drugs Market Size, Estimates and Forecasts
2.1.1 Global Urological Cancer Therapeutics Drugs Revenue 2016-2027
2.1.2 Global Urological Cancer Therapeutics Drugs Sales 2016-2027
2.2 Global Urological Cancer Therapeutics Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Urological Cancer Therapeutics Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Urological Cancer Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Urological Cancer Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Urological Cancer Therapeutics Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Region (2022-2027)
3 Global Urological Cancer Therapeutics Drugs Competitor Landscape by Players
3.1 Global Top Urological Cancer Therapeutics Drugs Manufacturers by Sales
3.1.1 Global Urological Cancer Therapeutics Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Urological Cancer Therapeutics Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Urological Cancer Therapeutics Drugs Manufacturers by Revenue
3.2.1 Key Urological Cancer Therapeutics Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Urological Cancer Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Urological Cancer Therapeutics Drugs Revenue in 2020
3.2.6 Global Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Urological Cancer Therapeutics Drugs Price by Manufacturers
3.4 Global Urological Cancer Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Urological Cancer Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Urological Cancer Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Urological Cancer Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Urological Cancer Therapeutics Drugs Market Size by Type (2016-2021)
4.1.1 Global Urological Cancer Therapeutics Drugs Sales by Type (2016-2021)
4.1.2 Global Urological Cancer Therapeutics Drugs Revenue by Type (2016-2021)
4.1.3 Urological Cancer Therapeutics Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Urological Cancer Therapeutics Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Urological Cancer Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Urological Cancer Therapeutics Drugs Market Size by Application (2016-2021)
5.1.1 Global Urological Cancer Therapeutics Drugs Sales by Application (2016-2021)
5.1.2 Global Urological Cancer Therapeutics Drugs Revenue by Application (2016-2021)
5.1.3 Urological Cancer Therapeutics Drugs Price by Application (2016-2021)
5.2 Urological Cancer Therapeutics Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Urological Cancer Therapeutics Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Urological Cancer Therapeutics Drugs Market Size YoY Growth 2016-2027
6.1.1 China Urological Cancer Therapeutics Drugs Sales YoY Growth 2016-2027
6.1.2 China Urological Cancer Therapeutics Drugs Revenue YoY Growth 2016-2027
6.1.3 China Urological Cancer Therapeutics Drugs Market Share in Global Market 2016-2027
6.2 China Urological Cancer Therapeutics Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Urological Cancer Therapeutics Drugs Players by Sales (2016-2021)
6.2.2 China Top Urological Cancer Therapeutics Drugs Players by Revenue (2016-2021)
6.3 China Urological Cancer Therapeutics Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Urological Cancer Therapeutics Drugs Price by Type (2016-2021)
6.4 China Urological Cancer Therapeutics Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Urological Cancer Therapeutics Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Urological Cancer Therapeutics Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Urological Cancer Therapeutics Drugs Price Forecast by Type (2022-2027)
6.5 China Urological Cancer Therapeutics Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Urological Cancer Therapeutics Drugs Price by Application (2016-2021)
6.6 China Urological Cancer Therapeutics Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Urological Cancer Therapeutics Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Urological Cancer Therapeutics Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Urological Cancer Therapeutics Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Urological Cancer Therapeutics Drugs Market Size YoY Growth 2016-2027
7.2 North America Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
7.2.1 North America Urological Cancer Therapeutics Drugs Sales by Country (2016-2021)
7.2.2 North America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Urological Cancer Therapeutics Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Urological Cancer Therapeutics Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Urological Cancer Therapeutics Drugs Market Size YoY Growth 2016-2027
9.2 Europe Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
9.2.1 Europe Urological Cancer Therapeutics Drugs Sales by Country (2016-2021)
9.2.2 Europe Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Urological Cancer Therapeutics Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
10.2.1 Latin America Urological Cancer Therapeutics Drugs Sales by Country (2016-2021)
10.2.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Urological Cancer Therapeutics Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Urological Cancer Therapeutics Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Urological Cancer Therapeutics Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Urological Cancer Therapeutics Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Description and Business Overview
12.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AstraZeneca Urological Cancer Therapeutics Drugs Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Astellas
12.5.1 Astellas Corporation Information
12.5.2 Astellas Description and Business Overview
12.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Astellas Urological Cancer Therapeutics Drugs Products Offered
12.5.5 Astellas Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Corporation Information
12.7.2 Abbott Laboratories Description and Business Overview
12.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbott Laboratories Urological Cancer Therapeutics Drugs Products Offered
12.7.5 Abbott Laboratories Recent Development
12.8 Celgene Corporation
12.8.1 Celgene Corporation Corporation Information
12.8.2 Celgene Corporation Description and Business Overview
12.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Celgene Corporation Urological Cancer Therapeutics Drugs Products Offered
12.8.5 Celgene Corporation Recent Development
12.9 Dendreon Corporation
12.9.1 Dendreon Corporation Corporation Information
12.9.2 Dendreon Corporation Description and Business Overview
12.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Products Offered
12.9.5 Dendreon Corporation Recent Development
12.10 Ferring Pharmaceuticals
12.10.1 Ferring Pharmaceuticals Corporation Information
12.10.2 Ferring Pharmaceuticals Description and Business Overview
12.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Products Offered
12.10.5 Ferring Pharmaceuticals Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Urological Cancer Therapeutics Drugs Products Offered
12.11.5 Novartis Recent Development
12.12 Indevus Pharmaceuticals Inc
12.12.1 Indevus Pharmaceuticals Inc Corporation Information
12.12.2 Indevus Pharmaceuticals Inc Description and Business Overview
12.12.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Indevus Pharmaceuticals Inc Products Offered
12.12.5 Indevus Pharmaceuticals Inc Recent Development
12.13 Ipsen
12.13.1 Ipsen Corporation Information
12.13.2 Ipsen Description and Business Overview
12.13.3 Ipsen Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Ipsen Products Offered
12.13.5 Ipsen Recent Development
12.14 Roche Healthcare
12.14.1 Roche Healthcare Corporation Information
12.14.2 Roche Healthcare Description and Business Overview
12.14.3 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Roche Healthcare Products Offered
12.14.5 Roche Healthcare Recent Development
12.15 Sanofi S.A.
12.15.1 Sanofi S.A. Corporation Information
12.15.2 Sanofi S.A. Description and Business Overview
12.15.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sanofi S.A. Products Offered
12.15.5 Sanofi S.A. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Urological Cancer Therapeutics Drugs Industry Trends
13.2 Urological Cancer Therapeutics Drugs Market Drivers
13.3 Urological Cancer Therapeutics Drugs Market Challenges
13.4 Urological Cancer Therapeutics Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Urological Cancer Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Xofigo (radium Ra 223 dichloride)
Table 3. Major Manufacturers of Jevtana (cabazitaxel)
Table 4. Major Manufacturers of Inlyta (axitinib)
Table 5. Major Manufacturers of Votrient (pazopanib hydrochloride)
Table 6. Major Manufacturers of Sutent (sunitinib malate)
Table 7. Major Manufacturers of Zytiga (abiraterone acetate)
Table 8. Major Manufacturers of Xtandi (enzalutamide)
Table 9. Major Manufacturers of Opdivo (nivolumab)
Table 10. Major Manufacturers of Provenge (sipuleucel-T)
Table 11. Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 12. Global Urological Cancer Therapeutics Drugs Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 13. Global Urological Cancer Therapeutics Drugs Sales by Regions (2016-2021) & (K MT)
Table 14. Global Urological Cancer Therapeutics Drugs Sales Market Share by Regions (2016-2021)
Table 15. Global Urological Cancer Therapeutics Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 16. Global Urological Cancer Therapeutics Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 17. Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Region (2022-2027)
Table 18. Global Urological Cancer Therapeutics Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 19. Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 20. Global Urological Cancer Therapeutics Drugs Sales by Manufacturers (2016-2021) (K MT)
Table 21. Global Urological Cancer Therapeutics Drugs Sales Share by Manufacturers (2016-2021)
Table 22. Ranking of Global Top Urological Cancer Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 23. Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 24. Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2016-2021)
Table 25. Global Urological Cancer Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 26. Global Urological Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urological Cancer Therapeutics Drugs as of 2020)
Table 27. Key Manufacturers Urological Cancer Therapeutics Drugs Price (2016-2021) (USD/MT)
Table 28. Urological Cancer Therapeutics Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Urological Cancer Therapeutics Drugs Product Type
Table 30. Date of International Manufacturers Enter into Urological Cancer Therapeutics Drugs Market
Table 31. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 32. Global Urological Cancer Therapeutics Drugs Sales by Type (2016-2021) (K MT)
Table 33. Global Urological Cancer Therapeutics Drugs Sales Share by Type (2016-2021)
Table 34. Global Urological Cancer Therapeutics Drugs Revenue by Type (2016-2021) (US$ Million)
Table 35. Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 36. Urological Cancer Therapeutics Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 37. Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 38. Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Type (2022-2027)
Table 39. Global Urological Cancer Therapeutics Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 40. Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 41. Global Urological Cancer Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 42. Global Urological Cancer Therapeutics Drugs Sales by Application (2016-2021) (K MT)
Table 43. Global Urological Cancer Therapeutics Drugs Sales Share by Application (2016-2021)
Table 44. Global Urological Cancer Therapeutics Drugs Revenue by Application (2016-2021) (US$ Million)
Table 45. Global Urological Cancer Therapeutics Drugs Revenue Share by Application (2016-2021)
Table 46. Urological Cancer Therapeutics Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 47. Global Urological Cancer Therapeutics Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 48. Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Application (2022-2027)
Table 49. Global Urological Cancer Therapeutics Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 50. Global Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 51. Global Urological Cancer Therapeutics Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 52. China Urological Cancer Therapeutics Drugs Sales (K MT) of Key Companies (2016-2021)
Table 53. China Urological Cancer Therapeutics Drugs Sales Share by Company (2016-2021)
Table 54. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) by Company (2016-2021)
Table 55. China Urological Cancer Therapeutics Drugs Revenue Share by Company (2016-2021)
Table 56. China Urological Cancer Therapeutics Drugs Sales (K MT) by Type (2016-2021)
Table 57. China Urological Cancer Therapeutics Drugs Sales Share by Type (2016-2021)
Table 58. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 59. China Urological Cancer Therapeutics Drugs Price (USD/MT) by Type (2016-2021)
Table 60. China Urological Cancer Therapeutics Drugs Sales (K MT) by Type (2022-2027)
Table 61. China Urological Cancer Therapeutics Drugs Sales Share by Type (2022-2027)
Table 62. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 63. China Urological Cancer Therapeutics Drugs Revenue Share by Type (2022-2027)
Table 64. China Urological Cancer Therapeutics Drugs Price (USD/MT) by Type (2022-2027)
Table 65. China Urological Cancer Therapeutics Drugs Sales (K MT) by Application (2016-2021)
Table 66. China Urological Cancer Therapeutics Drugs Sales Share by Application (2016-2021)
Table 67. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 68. China Urological Cancer Therapeutics Drugs Price (USD/MT) by Application (2016-2021)
Table 69. China Urological Cancer Therapeutics Drugs Sales (K MT) by Application (2022-2027)
Table 70. China Urological Cancer Therapeutics Drugs Sales Share by Application (2022-2027)
Table 71. China Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 72. China Urological Cancer Therapeutics Drugs Revenue Share by Application (2022-2027)
Table 73. China Urological Cancer Therapeutics Drugs Price (USD/MT) by Application (2022-2027)
Table 74. North America Urological Cancer Therapeutics Drugs Sales by Country (2016-2021) & (K MT)
Table 75. North America Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 76. North America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 77. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 78. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2016-2021) & (K MT)
Table 79. Asia Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 80. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Table 82. Europe Urological Cancer Therapeutics Drugs Sales by Country (2016-2021) & (K MT)
Table 83. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 84. Europe Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 85. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 86. Latin America Urological Cancer Therapeutics Drugs Sales by Country (2016-2021) & (K MT)
Table 87. Latin America Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 88. Latin Americaa Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 89. Latin America Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 90. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country (2016-2021) & (K MT)
Table 91. Middle East and Africa Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 92. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 93. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Business Overview
Table 96. Novartis Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 97. Novartis Urological Cancer Therapeutics Drugs Product
Table 98. Novartis Recent Development
Table 99. Pfizer Corporation Information
Table 100. Pfizer Description and Business Overview
Table 101. Pfizer Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 102. Pfizer Product
Table 103. Pfizer Recent Development
Table 104. Johnson & Johnson Corporation Information
Table 105. Johnson & Johnson Description and Business Overview
Table 106. Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Recent Development
Table 109. AstraZeneca Corporation Information
Table 110. AstraZeneca Description and Business Overview
Table 111. AstraZeneca Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 112. AstraZeneca Product
Table 113. AstraZeneca Recent Development
Table 114. Astellas Corporation Information
Table 115. Astellas Description and Business Overview
Table 116. Astellas Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 117. Astellas Product
Table 118. Astellas Recent Development
Table 119. Bristol-Myers Squibb Corporation Information
Table 120. Bristol-Myers Squibb Description and Business Overview
Table 121. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 122. Bristol-Myers Squibb Product
Table 123. Bristol-Myers Squibb Recent Development
Table 124. Abbott Laboratories Corporation Information
Table 125. Abbott Laboratories Description and Business Overview
Table 126. Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 127. Abbott Laboratories Product
Table 128. Abbott Laboratories Recent Development
Table 129. Celgene Corporation Corporation Information
Table 130. Celgene Corporation Description and Business Overview
Table 131. Celgene Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 132. Celgene Corporation Product
Table 133. Celgene Corporation Recent Development
Table 134. Dendreon Corporation Corporation Information
Table 135. Dendreon Corporation Description and Business Overview
Table 136. Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 137. Dendreon Corporation Product
Table 138. Dendreon Corporation Recent Development
Table 139. Ferring Pharmaceuticals Corporation Information
Table 140. Ferring Pharmaceuticals Description and Business Overview
Table 141. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 142. Ferring Pharmaceuticals Product
Table 143. Ferring Pharmaceuticals Recent Development
Table 144. GlaxoSmithKline plc Corporation Information
Table 145. GlaxoSmithKline plc Description and Business Overview
Table 146. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. GlaxoSmithKline plc Product
Table 148. GlaxoSmithKline plc Recent Development
Table 149. Indevus Pharmaceuticals Inc Corporation Information
Table 150. Indevus Pharmaceuticals Inc Description and Business Overview
Table 151. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Indevus Pharmaceuticals Inc Product
Table 153. Indevus Pharmaceuticals Inc Recent Development
Table 154. Ipsen Corporation Information
Table 155. Ipsen Description and Business Overview
Table 156. Ipsen Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 157. Ipsen Product
Table 158. Ipsen Recent Development
Table 159. Roche Healthcare Corporation Information
Table 160. Roche Healthcare Description and Business Overview
Table 161. Roche Healthcare Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 162. Roche Healthcare Product
Table 163. Roche Healthcare Recent Development
Table 164. Sanofi S.A. Corporation Information
Table 165. Sanofi S.A. Description and Business Overview
Table 166. Sanofi S.A. Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 167. Sanofi S.A. Product
Table 168. Sanofi S.A. Recent Development
Table 169. Urological Cancer Therapeutics Drugs Market Trends
Table 170. Urological Cancer Therapeutics Drugs Market Drivers
Table 171. Urological Cancer Therapeutics Drugs Market Challenges
Table 172. Urological Cancer Therapeutics Drugs Market Restraints
Table 173. Urological Cancer Therapeutics Drugs Customers List
Table 174. Urological Cancer Therapeutics Drugs Distributors List
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Urological Cancer Therapeutics Drugs Product Picture
Figure 2. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Xofigo (radium Ra 223 dichloride) Product Picture
Figure 4. Jevtana (cabazitaxel) Product Picture
Figure 5. Inlyta (axitinib) Product Picture
Figure 6. Votrient (pazopanib hydrochloride) Product Picture
Figure 7. Sutent (sunitinib malate) Product Picture
Figure 8. Zytiga (abiraterone acetate) Product Picture
Figure 9. Xtandi (enzalutamide) Product Picture
Figure 10. Opdivo (nivolumab) Product Picture
Figure 11. Provenge (sipuleucel-T) Product Picture
Figure 12. Glo

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs